Beerse, Belgium

Gopal Rajan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Janssen Pharmaceutica Nv, Protagonist Therapeutics, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gopal Rajan. Retrieved from https://idiyas.com/inventor/gopal-rajan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gopal Rajan: Innovator in Peptide Inhibitors

Introduction

Gopal Rajan is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of peptide inhibitors.

Latest Patents

Gopal Rajan holds 1 patent for his invention titled "Compositions of peptide inhibitors of Interleukin-23 receptor." This invention relates to compositions of peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salt or solvate forms thereof. It also includes corresponding pharmaceutical compositions, methods, and uses for the treatment of autoimmune inflammation and related diseases and disorders.

Career Highlights

Throughout his career, Gopal Rajan has worked with prominent companies in the pharmaceutical industry. He has been associated with Janssen Pharmaceutica NV and Protagonist Therapeutics, Inc., where he has contributed to innovative research and development.

Collaborations

Gopal Rajan has collaborated with esteemed colleagues, including Giustino Di Pretoro and Dajun Sun, enhancing the impact of his work in the field.

Conclusion

Gopal Rajan's contributions to the development of peptide inhibitors highlight his role as an innovator in the pharmaceutical industry. His work continues to influence the treatment of autoimmune diseases and disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…